Prestige Consumer Healthcare Inc. Stock
Prestige Consumer Healthcare Inc. dominated the market today, gaining €1.60 (3.430%).
Currently there is a rather positive sentiment for Prestige Consumer Healthcare Inc. with 3 Buy predictions and 0 Sell predictions.
With a target price of 64 € there is a positive potential of 32.78% for Prestige Consumer Healthcare Inc. compared to the current price of 48.2 €.
Pros and Cons of Prestige Consumer Healthcare Inc. in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Prestige Consumer Healthcare Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Prestige Consumer Healthcare Inc. | 3.430% | 3.879% | -8.190% | -30.647% | -9.907% | -16.174% | 28.191% |
| Apollo Medical Holdings, Inc. | 0.000% | 2.500% | 16.038% | -12.766% | 16.038% | -32.044% | - |
| Petmed Express Inc | -2.650% | 0.405% | -7.506% | -25.498% | -31.254% | -86.038% | -92.614% |
| Suzuken Co Ltd | 0.000% | -4.217% | 0.633% | 27.200% | -3.049% | 27.200% | 1.274% |
Comments
Prestige Consumer Healthcare (NYSE:PBH) had its price target lowered by analysts at Oppenheimer Holdings, Inc. from $82.00 to $72.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for PBH provided by MarketBeat
Prestige Consumer Healthcare (NYSE:PBH) was upgraded by analysts at Sidoti from a "neutral" rating to a "buy" rating. They now have a $80.00 price target on the stock.
Show more
Ratings data for PBH provided by MarketBeat
Prestige Consumer Healthcare Inc. (NYSE: PBH) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for PBH provided by MarketBeat